Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Enhancing these processes involves adjusting various variables, including cell line development, media composition, and bioreactor environments. A key goal is to amplify antibody titer while lowering production financ